Stay updated on AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Sign up to get notified when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.

Latest updates to the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page
- Check3 days agoChange DetectedAdded a Publications section with Quemliclustat and zimberelimab in metastatic pancreatic adenocarcinoma (Nat Med 2026) and PubMed notes. Updated Locations: removed Medical Oncology Associates (Spokane) and changed total locations from 14 to 13.SummaryDifference0.5%

- Check10 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page revision history.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check38 days agoChange DetectedUpdated the study locations: the page now lists 14 locations (as of 2026-02-27), replacing the previous 17-location listing and removing several sites.SummaryDifference0.5%

- Check52 days agoChange DetectedRemoved a site (Mid-Florida Hematology & Oncology Centers, PA) and its Orange City, FL address. The total number of locations is now listed as 17 (revision: v3.4.2).SummaryDifference0.3%

- Check60 days agoChange DetectedMinor version update from Revision: v3.4.0 to v3.4.1 with no visible changes to study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to AB680 Safety in Gastrointestinal Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB680 Safety in Gastrointestinal Malignancies Clinical Trial page.